Recursion Pharmaceuticals RXRX
NASDAQ RXRX
$4.03 +0.33 (+8.78%)
As of: Sep 29, 2026 · 3:59 PM EDT

Recursion Pharmaceuticals (RXRX) Gross Margin (2021 - 2026)

Updated

Recursion Pharmaceuticals (RXRX) posted Gross Margin of -49.82% for Q2 2026, down 44.94 percentage points from -4.88% a year earlier but up 43.17 percentage points from the prior quarter.

Analysis

Recursion Pharmaceuticals (RXRX) Gross Margin (2021 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Gross Margin at Recursion Pharmaceuticals was 3.49%, up 7.00 percentage points year-over-year; for FY2025, it was 4.99%, down 18.12 percentage points from FY2024.

  • Annual Gross Margin shows a five-year change of -95.01 percentage points (FY2020 to FY2025).
  • In prior years, Recursion Pharmaceuticals' Gross Margin was 23.12% in FY2024 (+18.66 pp), 4.46% in FY2023 (+25.62 pp), -21.16% in FY2022 (-121.16 pp) and 100.00% in FY2021 (unchanged).
  • Quarterly Gross Margin has run from a low of -183.81% in Q3 2025 to a high of 100.00% in Q4 2021 over five years.
  • On a year-over-year basis, Gross Margin increased in two of the last eight quarters, with an average year-over-year change of -41.00 percentage points.
  • The strongest year-over-year quarter for Gross Margin in the past five years was Q4 2025, with a gain of 241.27 percentage points; the weakest was Q3 2025, with a drop of 237.50 percentage points.
  • According to Business Quant data, Gross Margin for the three prior quarters was -92.99% (Q1 2026), 59.83% (Q4 2025) and -183.81% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 68.19%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 74.74%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 73.54%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 78.02%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 83.60%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 72.04%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 79.76%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 85.33%
10 Recursion Pharmaceuticals 1.98 Bn -627.04 Mn -3.82 Mn -49.82%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -49.82%
Mar 31, 2026 -92.99%
Dec 31, 2025 59.83%
Sep 30, 2025 -183.81%
Jun 30, 2025 -4.88%
Mar 31, 2025 -48.04%
Dec 31, 2024 -181.43%
Sep 30, 2024 53.69%
Jun 30, 2024 36.19%
Mar 31, 2024 19.05%
Dec 31, 2023 9.27%
Sep 30, 2023 -3.27%
Jun 30, 2023 14.84%
Mar 31, 2023 -2.59%
Dec 31, 2022 20.74%
Sep 30, 2022 -17.09%
Jun 30, 2022 -85.39%
Mar 31, 2022 -46.24%
Dec 31, 2021 100.00%
Sep 30, 2021 100.00%
API Access

Recursion Pharmaceuticals Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=RXRX&period=max&api_key=YOUR_API_KEY